| Literature DB >> 33959009 |
Linlin Jiang1, Guoqing Zhang2,1, Ye Li2, Guirong Shi3, Minhui Li1,4,5.
Abstract
Immune dysfunction, which is responsible for the development of human diseases including cancer, is caused by a variety of factors. Therefore, regulation of the factors influencing the immune response is a potentially effective strategy to counter diseases. Presently, several immune adjuvants are used in clinical practice to enhance the immune response and host defense ability; however, synthetic drugs can exert negative side effects. Thus, the search for natural products of plant origin as new leads for the development of potent and safe immune boosters is gaining considerable research interest. Plant-based functional foods have been shown to exert several immunomodulatory effects in humans; therefore, the application of new agents to enhance immunological and specific host defenses is a promising approach. In this comprehensive review, we have provided an up-to-date report on the use as well as the known and potential mechanisms of bioactive compounds obtained from plant-based functional foods as natural immune boosters. Plant-based bioactive compounds promote immunity through multiple mechanisms, including influencing the immune organs, cellular immunity, humoral immunity, nonspecific immunity, and immune-related signal transduction pathways. Enhancement of the immune response in a natural manner represents an excellent prospect for disease prevention and treatment and is worthy of further research and development using approaches of modern science and technology.Entities:
Keywords: bioactive compound; disease treatment; immune booster; immune system; plant-based functional food
Year: 2021 PMID: 33959009 PMCID: PMC8096308 DOI: 10.3389/fphar.2021.637782
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1The immune system of innate and adaptive immunity.
Experiment and mechanism of polysaccharides bioactive components from plant-based functional foods on immune enhancement.
| Source | Bioactive Compound | Model Type | Effective Dose | Effects | Mechanisms | References |
|---|---|---|---|---|---|---|
|
| yam polysaccharide | Lewis cells of lung cancer (B) | 150 mg/kg | ↑ IL-2, TNF-α, T lymphocyte proliferation, and the activity of NK cells. | They play an immune-enhancing role by promoting the activity of immune cells and related factors. |
|
|
| yam polysaccharide | Cyclophosphamide-induced immunosuppressive mice (A) | 250 mg/kg | The liver index and white blood cell count significantly improved. | They achieve immune enhancement by regulating immune organs and cells. |
|
|
| codonopsis pilosula Polysaccharide | Cyclophosphamide-induced immunosuppressive mice (A) | 200 mg/kg | It promotes lymphocyte proliferation | The thymus index, spleen index and immune related factors were improved, and the immunity function was enhanced. |
|
|
| lycium barbarum polysaccharide | Cyclophosphamide-induced immunosuppressive mice (A) | 200 mg/kg | It enhances immune organ indexes and alleviating immune organ damage, enhance the production of immune-related cytokines (IL-2, IL-6, IL-1β, TNF-α and IFN-γ). | They play an immune-enhancing role by promoting the activity of immune cells and related factors. |
|
|
| gynostemma pentaphyllum polysaccharide | Cyclophosphamide-induced immunosuppressive mice (A) | 400 mg/kg | ↑ IL-4, IgG, IgM, the spleen and thymus indexes, macrophage and splenic lymphocyte activity. | The thymus index, spleen index and immune related factors were enhanced. |
|
|
| ginkgobiloba leaves polysaccharide | SPF chickens (A) | 40 g/L | ↑ IL-2 and IFN-γ, CD4+ and CD8+ T lymphocyte number | Promote humoral immunity and cellular immunity, and have a good role in immune promotion |
|
|
| platycodon polysaccharide | SPF mice cells (B) | 100 μg/ml | It can selectively activates B cells and macrophages. | They play an immune-enhancing role by promoting the activity of immune cells. |
|
|
| angelica sinensis polysaccharide | Solid tumor mouse (A) | 200 mg/kg | ↑ immune organ index, TNF-α, IL-1β and IL-6 | TLR4 signaling pathway may be involved in the immunomodulatory effects. |
|
|
|
| chickens (A) | 20 g/kg | ↑ the mmune organs index, IL-2, IL-12 TNF-α, the activity of NK cells. | It can promote the development of immune organs and secretion of related cytokines, so as to improve immune performance. |
|
|
| radix Pseudostellariae | Cyclophosphamide-induced immunosuppressive mice (A) | 50 mg/kg | ↑ immune organ index, IgA, IgG, IgM, IL-2, IL-4, IL-6 and IFN-γ. | It can promote the development of immune organs and secretion of related cytokines. |
|
|
| litchi pulp polysaccharides | Cyclophosphamide-induced immunosuppressive mice (A) | 200 mg/kg | ↑ IL-6, TNF-α, IgG, IgA, IgM, immune organ index. | It can stimulate the proliferation of splenocytes, balancing the ratio of spleen lymphocyte subsets, up-regulating the thymus and spleen indices. |
|
|
|
| Mouse lymphocytes (B) | 200 μg/ml | ↑ IL-2, IL-6, IL-10 and the proliferation of T lymphocytes. | It can promote lymphocyte proliferative response |
|
|
| jujube | Mouse lymphocytes (B) | 160 μg/ml | ↑ the mRNA of IL-2, IL-6, IL-10, IL-12 and lymphocyte multiplication | It can improve the immune function by inducing lymphocyte proliferation, lymphocyte cytokine secretion and mRNA expression. |
|
FIGURE 2The immune enhancement effects of saponins in plant-based functional foods.
Experiment of saponins in plant-based functional foods on immune enhancement.
| Source | Compound | Model Type | Effective Dose | Effects | Mechanisms | References |
|---|---|---|---|---|---|---|
|
| polygala saponins | Cyclophosphamide-induced immunosuppressive mice (A) | 400 mg/kg | ↑ spleen index, thymus index, IL-2 | The mechanism is related to the regulation of cytokines. |
|
|
| ginsenoside Rg1 | Cyclophosphamide-induced immunosuppressive mice (A) | 400 mg/kg | It could significantly increase the positive rate of antibody , spleen and bursa index and intestinal total sIgA and specific sIgA content compared with the C group, as well as up-regulated the mRNA expression of TLR4, p65, TGF-β, pIgR and CCR9genes in the chicken duodenum. | It acts on TLR4 receptors to exert immunomodulatory effects. |
|
|
| notoginsenoside R1 | Traumatic shock rats (A) | 50 mg/kg | ↓ TNF-α, IL-1β, iNOS, p-p65, ERK1/2/p-ERK1/2 | It can enhance the immune response by blocking ERK1/2 and NF-κB signaling pathways, and regulate expression levels of inflammatory factors. |
|
|
| tea saponin | Cyclophosphamide-induced chickens (A) | 5 mg/kg | The lymphocyte proliferation and serum virus-specific antibodies were increased. | It could increase the specific antibody response to enhance immune function. |
|
|
| ginseng stem-leaf saponins | Vaccinated mice (A) | 50 μg | ↑ IgG1, IgG2a, IgG2b, IFN-γ and IL-4 | It could enhance cellular and humoral immune response to enhance immune function. |
|
|
| american ginseng saponins | Rapamycin-induced zebrafish (A) | 25 μg/ml | ↑ IFN-γ | It can increase the function of immune cells and promote the secretion of cytokines. |
|
|
| ginsenoside Rg1 | Cyclophosphamide-induced chickens (A) | 1 mg/kg | ↑ SIgA, TLR4, p65, TGF-β, pIgR, and spleen and bursa of Fabricius index | It can restore the function of suppressed immune organs to improve the immune response. |
|
|
| ginsenoside Rg1 | Type Ⅲ prostatitis rats (A) | 40 mg/kg |
| It can regulate immune balance by inducing the secretion of cytokines. |
|
|
| ginsenoside Rg2 | Patients with lung cancer (C) | 0.5 g/d | ↑ CD3+, CD4+, CD4+/CD8+
| It can regulate lymphocytes to protect immune function. |
|
|
| ginsenoside Rg3 | Patients with gastric cancer (C) | 40 mg/d | ↑ CD3+, CD4+, CD4+/CD8+, T lymphocyte transformation rate | It can regulate lymphocytes to protect immune function. |
|
|
| ginsenoside Rg3 | Nasopharyngeal carcinoma in patients (C) | 100 mg/L | ↑ CD4+, CD4+/CD8+, IgG, CD 80/86, IgM, IL-2 | It can signifi cantly enhance the immune function by promoting the proliferation of lymphocytes, and regulating immune factors. |
|
|
| total momordicoside | Nephropathy of rats (A) | 20 mg/kg |
| It can inhibit the expression of TGF-β1, thereby reducing the serum IL-2 and IL-6. |
|
|
| notoginsenosideS-6 | Con A-Splenic lymphocyte of mice (B) | 1 μg/ml | Increased T, and B lymphocyte proliferative | It can significantly promote the proliferation of T and B lymphocytes and enhance immune function. |
|
|
| notoginsenosideS-6 | Con A-Splenic lymphocyte of mice (B) | 25 μg/ml | ↑ IL-2 | As an activator, IL-2 induces T lymphocytes to express IL-2R, which in turn induces the production of IL-2 to play an immune role. |
|
|
| platycodin D | Lymphocyte and macrophage of mice (B) | 50 μg/ml | ↑ IL-2, IL-4, TNF-α, and IL-12 | It can enhance the activity of lymphocytes and macrophages to regulate the immune function. |
|
|
| Iso-astragaloside VI | Lymphocyte and macrophage of mice (B) | 50 μg/ml | ↑ IL-1, IL-2, IL-6, and IL-12 p70, the phagocytosis of macrophages | It is related to the enhancement of the secretion capacity of dendritic cells, and the promotion of non-specific immune phagocytosis and lymphocyte proliferation. |
|
Flavonoids components in plant-based functional foods on immune enhancement.
| Source | Compound | Model Type | Effective Dose | Main Results | Mechanisms | References |
|---|---|---|---|---|---|---|
|
| Apigenin | LPS-induced spleen cells (B) | 20 μM |
| The mechanism is related to inhibiting DCs activation and function. |
|
|
| soy isoflavones | Rats (A) | 50 mg/kg |
| It can regulate the expression levels of cytokines to enhance immunity. |
|
|
| isoliquiritigenin | LPS-induced bone marrow-derived macrophages (B) | 40 μM |
| It may inhibit Mincle/Syk/NF-kappa B signaling pathway in macrophage to exert anti-inflammatory effects. |
|
|
| proanthocyanidins | Cyclophosphamide-immunosuppression mice (A) | 100 mg/kg | ↑ Thymus and spleen index, TNF-α, and TNF-α mRNA. | It can regulate the secretion of cytokines and enhance immunity. |
|
|
| proanthocyanidins | B16F10 tumor cells (B) | 80 μg/ml | ↑ IL-12, and TNF-α | It enhances the immune response mediated by T cells and plays an immunological enhancement role. |
|
|
| seabuckthorn flavones | Dendritic cell (B) | 200 μg/ml | ↑ antigen presenting molecules HLA-DR, CD80, CD83 and CD86. | It can improve the antigen presentation ability of dendritic cell and promote the maturation of dendritic cell phenotype. |
|
|
| luteolin | LPS-induced RAW264.7 cells (B) | 1 μM |
| It regulate NF-κB and the secretion of cytokines to enhance the immunoregulative effect. |
|
|
| luteolin-7-O-glucoside | LPS-induced mice splenocytes, and macrophages (B) | 4.48 μg/ml | NK cell activity and the proliferation of T lymphocytes increased, as well as macrophage lysosomal activity decreased. | It exhibites important immune enhancement activity by regulating NK cell activity and the proliferation of T lymphocytes. |
|
|
| genistein | LPS-induced broiler chicks (A) | 5 mg/kg | The immune spleen, thymus and bursa indices were increased. | It can promote the development of immune organs to play immune function. |
|
|
| rutin | Cyclophosphamide-induced rats (A) | 50 mg/kg | The phagocytic index, total leukocyte count, and serum immunoglobulin levels were in increased. | It can stimulate humoral and cellular responses to enhance the immunoregulative effect. |
|
|
| quercetin | Chickens (A) | 4 g/kg | The indexes of spleen, bursa of Fabricius and thymus, and the phagocytic function of macrophages were improved. | It can promote the development of spleen, bursa and thymus, improve the phagocytosis of macrophages, and induce the secretion of cytokine to improve the immune function of the body. |
|
|
| quercetin | ConA or LPS-stimulated lymphocytes (B) | 20 μM | ↑ IL-2 and IFN-γ in lymphocytes. | It can promote lymphocyte proliferation and cytokine secretion. |
|
|
| flavone from Eucommia ulmoides Oliv. | ConA or LPS-stimulated lymphocytes (B) | 20 μM | ↑ IL-2 and IFN-γ in lymphocytes. | It can regulate the secretion of cytokines and enhance immunity. |
|
|
| kaempferol | Cold-stress mice (A) | 25 mg/kg |
| It boosts immunity by inhibiting the activation of pro-inflammatory factors. |
|
|
| puerarin | Gouty arthritis mice (A) | 100 mg/kg |
| It may play an immune-enhancing role by influencing the expression level of inflammatory cytokines. |
|
|
| puerarin | Viral myocarditis in children (C) | 40 mg/ml | ↑ CD3+, CD4+, and CD4+/CD8+
| It can reduce the level of inflammatory factors to improve its immune function. |
|
FIGURE 3The immune enhancement effects of flavonoids in plant-based functional foods.
FIGURE 4The immune enhancement effects of alkaloids and other components in plant-based functional food.
Other components in plant-based functional foods on immune enhancement.
| Source | Compound | Model Type | Effective Dose | Main Results | Mechanisms | References |
|---|---|---|---|---|---|---|
|
| curcumin | Colitis mice (A) | 200 mg/kg |
| It can enhance immunity by inhibiting the expression of pro-inflammatory factors and increasing the secretion of anti-inflammatory factors. |
|
|
| ursolic acid | Mouse lymphocytes (A) | 200 mg/kg |
| It can enhance immunity by inhibiting the expression of pro-inflammatory factors and increasing the secretion of anti-inflammatory factors. |
|
|
| chlorogenic acid | LPS-induced RAW264.7 cells (B) | 1 μM |
| It regulate NF-κB and the secretion of cytokines to enhance the immunoregulative effect. |
|
(A): in vivo.
(B): in vitro.
(C): in human.
↑: enhanced effects.
↓: inhibited effects.
FIGURE 5The receptors and signaling pathways triggered by plant-based functional foods.
FIGURE 6The immune system of immune organs.